Dr. Dew is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
Walter Reed National Military Ctr
Bethesda, MD 20889Phone+1 301-319-8361
Education & Training
National Capital ConsortiumFellowship, Hematology and Medical Oncology, 2017 - 2020- National Capital ConsortiumResidency, Internal Medicine, 2014 - 2017
Chicago College of Osteopathic Medicine at Midwestern UniversityClass of 2014
Certifications & Licensure
VA State License 2014 - 2026- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- Survival Among Patients With Multiple Myeloma in the United States Military Health System Compared to the Surveillance, Epidemiology, and End Results (SEER) Program.Alexander Dew, Jie Lin, Sarah Darmon, Joe Roswarski, Craig Shriver
Clinical Lymphoma, Myeloma & Leukemia. 2024-11-01 - 14 citationsCarfilzomib, Lenalidomide, and Dexamethasone Followed by Lenalidomide Maintenance for Prevention of Symptomatic Multiple Myeloma in Patients With High-risk Smoldering ...Dickran Kazandjian, Elizabeth M. Hill, Alexander Dew, Candis Morrison, Joseph Roswarski
JAMA Oncology. 2021-11-01 - 10 citationsAvelumab, a PD-L1 Inhibitor, in Combination with Hypofractionated Radiotherapy and the Abscopal Effect in Relapsed Refractory Multiple Myeloma.Dickran Kazandjian, Alexander Dew, Elizabeth M. Hill, Elizabeth Gil Ramirez, Candis Morrison
The Oncologist. 2021-04-01
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
